BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28527397)

  • 1. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
    Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
    Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts.
    McDonald ES; Hammersley JA; Chou SH; Rahbar H; Scheel JR; Lee CI; Liu CL; Lehman CD; Partridge SC
    AJR Am J Roentgenol; 2016 Jul; 207(1):205-16. PubMed ID: 27077731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts.
    Zhang Z; Wang W; Wang X; Yu X; Zhu Y; Zhan H; Chen Z; Li B; Huang J
    Eur Radiol; 2020 Nov; 30(11):6062-6071. PubMed ID: 32524221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
    Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
    Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
    Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
    AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
    Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
    Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk.
    Brem RF; Ruda RC; Yang JL; Coffey CM; Rapelyea JA
    J Nucl Med; 2016 May; 57(5):678-84. PubMed ID: 26823569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
    Narayan AK; Visvanathan K; Harvey SC
    Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First experiences in screening women at high risk for breast cancer with MR imaging.
    Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
    Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI of occult breast carcinoma in a high-risk population.
    Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
    AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Breast Cancer Res Treat; 2017 Nov; 166(1):145-156. PubMed ID: 28702891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
    Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J
    BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
    Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
    Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions.
    Bedrosian I; Schlencker J; Spitz FR; Orel SG; Fraker DL; Callans LS; Schnall M; Reynolds C; Czerniecki BJ
    Ann Surg Oncol; 2002 Jun; 9(5):457-61. PubMed ID: 12052756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.
    Wang J; Greuter MJW; Vermeulen KM; Brokken FB; Dorrius MD; Lu W; de Bock GH
    Breast; 2022 Feb; 61():58-65. PubMed ID: 34915447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying women with dense breasts at high risk for interval cancer: a cohort study.
    Kerlikowske K; Zhu W; Tosteson AN; Sprague BL; Tice JA; Lehman CD; Miglioretti DL;
    Ann Intern Med; 2015 May; 162(10):673-81. PubMed ID: 25984843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer detection rate of breast-MR in supplemental screening after negative mammography in women with dense breasts. Preliminary results of the MA-DETECT-Study after 200 participants.
    Kaiser C; Wilhelm T; Walter S; Singer S; Keller E; Baltzer PAT
    Eur J Radiol; 2024 Jul; 176():111476. PubMed ID: 38710116
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.